511 related articles for article (PubMed ID: 12964887)
1. Drug treatment of stable angina pectoris in the elderly: defining the place of calcium channel antagonists.
Kumar S; Hall RJ
Drugs Aging; 2003; 20(11):805-15. PubMed ID: 12964887
[TBL] [Abstract][Full Text] [Related]
2. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
Kurz T; Rauch B; Kübler W
Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
[TBL] [Abstract][Full Text] [Related]
3. Calcium ions, drug action and the heart--with special reference to calcium antagonist drugs.
Opie LH
Pharmacol Ther; 1984; 25(3):271-95. PubMed ID: 6151199
[TBL] [Abstract][Full Text] [Related]
4. The role of calcium antagonists in the treatment of myocardial ischemia.
Follath F
Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
[TBL] [Abstract][Full Text] [Related]
5. Calcium channel antagonists should be among the first-line drugs in the management of cardiovascular disease.
Opie LH
Cardiovasc Drugs Ther; 1996 Sep; 10(4):455-61. PubMed ID: 8924059
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers in patients with both hypertension and angina pectoris.
Frishman WH; Lazar EJ
J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S69-74. PubMed ID: 2468912
[TBL] [Abstract][Full Text] [Related]
7. Mibefradil: a new class of calcium-channel antagonists.
Billups SJ; Carter BL
Ann Pharmacother; 1998 Jun; 32(6):659-71. PubMed ID: 9640486
[TBL] [Abstract][Full Text] [Related]
8. Choosing the most appropriate treatment for stable angina. Safety considerations.
Asirvatham S; Sebastian C; Thadani U
Drug Saf; 1998 Jul; 19(1):23-44. PubMed ID: 9673856
[TBL] [Abstract][Full Text] [Related]
9. Calcium-channel blockers for combined angina pectoris and systemic hypertension.
Frishman WH; Charlap S; Kimmel B; Goldberger J; Phillippides G; Klein N
Am J Cardiol; 1986 Feb; 57(7):22D-29D. PubMed ID: 3513513
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
Heidenreich PA; McDonald KM; Hastie T; Fadel B; Hagan V; Lee BK; Hlatky MA
JAMA; 1999 May; 281(20):1927-36. PubMed ID: 10349897
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.
Opie LH
Cardiovasc Drugs Ther; 1988 Jan; 1(5):461-91. PubMed ID: 3154677
[TBL] [Abstract][Full Text] [Related]
12. First line drugs in chronic stable effort angina--the case for newer, longer-acting calcium channel blocking agents.
Opie LH
J Am Coll Cardiol; 2000 Nov; 36(6):1967-71. PubMed ID: 11092672
[TBL] [Abstract][Full Text] [Related]
13. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
Friedel HA; Sorkin EM
Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
[TBL] [Abstract][Full Text] [Related]
14. Angina pectoris in patients with a history of myocardial infarction.
Sellier P
Eur Heart J; 1996 Dec; 17 Suppl G():25-9. PubMed ID: 8960452
[TBL] [Abstract][Full Text] [Related]
15. Current treatment of hypertension in patients with coronary artery disease recommended by different guidelines.
Aronow WS
Expert Opin Pharmacother; 2016; 17(2):205-15. PubMed ID: 26373919
[TBL] [Abstract][Full Text] [Related]
16. Ivabradine: beyond heart rate control.
Riccioni G; Vitulano N; D'Orazio N
Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
[TBL] [Abstract][Full Text] [Related]
17. Mibefradil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of hypertension and angina pectoris.
Brogden RN; Markham A
Drugs; 1997 Nov; 54(5):774-93. PubMed ID: 9360062
[TBL] [Abstract][Full Text] [Related]
18. Calcium-channel blockers in ischemic heart disease.
Silvestry FE; Kimmel SE
Curr Opin Cardiol; 1996 Jul; 11(4):434-9. PubMed ID: 8879955
[TBL] [Abstract][Full Text] [Related]
19. Defining the role of calcium channel antagonists in heart failure due to systolic dysfunction.
Mahé I; Chassany O; Grenard AS; Caulin C; Bergmann JF
Am J Cardiovasc Drugs; 2003; 3(1):33-41. PubMed ID: 14727944
[TBL] [Abstract][Full Text] [Related]
20. Verapamil in the long-term treatment of angina pectoris.
Raftos J
Clin Exp Pharmacol Physiol Suppl; 1982; 6():43-9. PubMed ID: 6811176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
